Publications
Detailed Information
Hepatic Resection Versus Radiofrequency Ablation for Very Early Stage Hepatocellular Carcinoma: A Markov Model Analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Yun Ku | - |
dc.contributor.author | Kim, Jae Kyun | - |
dc.contributor.author | Kim, Wan Tae | - |
dc.contributor.author | Chung, Jin Wook | - |
dc.date.accessioned | 2012-07-04T04:46:13Z | - |
dc.date.available | 2012-07-04T04:46:13Z | - |
dc.date.issued | 2010-04 | - |
dc.identifier.citation | HEPATOLOGY; Vol.51 4; 1284-1290 | ko_KR |
dc.identifier.issn | 0270-9139 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78397 | - |
dc.description.abstract | No adequate randomized trials have been reported for a comparison between hepatic resection (HR) versus radiofrequency ablation (RFA) for the treatment of patients with very early stage hepatocellular carcinoma (HCC), defined as an asymptomatic solitary HCC <2 cm. For compensated cirrhotic patients with very early stage HCC, a Markov model was created to simulate a randomized trial between HR (group I) versus primary percutaneous RFA followed by HR for cases of initial local failure (group II) versus percutaneous RFA monodierapy (group III); each arm was allocated with a hypothetical cohort of 10,000 patients. The primary endpoint was overall survival. The estimates of the variables were extracted from published articles after a systematic review. In the parameter estimations, we assumed the best scenario for HR and the worst scenario for RFA. The mean expected survival was 7.577 years, 7.564 years, and 7.356 years for group I, group II, and group III, respectively. One-way sensitivity analysis demonstrated that group II was the preferred strategy if the perioperative mortality rate was greater than 1.0%, if the probability of local recurrence following an initial complete ablation was <1.9% or if the positive microscopic resection margin rate was >0.3%. The 95% confidence intervals for the difference in overall survival were -0.18-0.18 years between group I and II, 0.06-0.36 years between group I and III, and 0.13-0.30 years between group II and III, respectively. Conclusion: Primary percutaneous RFA followed by HR for cases of initial local failure was nearly identical to HR for the overall survival of compensated cirrhotic patients with very early stage HCC. (HEPATOLOGY 2010; 51:1284-1290.) | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | JOHN WILEY & SONS INC | ko_KR |
dc.title | Hepatic Resection Versus Radiofrequency Ablation for Very Early Stage Hepatocellular Carcinoma: A Markov Model Analysis | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 조윤구 | - |
dc.contributor.AlternativeAuthor | 김재균 | - |
dc.contributor.AlternativeAuthor | 김완태 | - |
dc.contributor.AlternativeAuthor | 정진욱 | - |
dc.identifier.doi | 10.1002/hep.23466 | - |
dc.citation.journaltitle | HEPATOLOGY | - |
dc.description.citedreference | Molinari M, 2009, AM J SURG, V198, P396, DOI 10.1016/j.amjsurg.2009.01.016 | - |
dc.description.citedreference | Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31 | - |
dc.description.citedreference | Farinati F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-33 | - |
dc.description.citedreference | LAI CH, 2009, WORLD J SURG, V33, P2150 | - |
dc.description.citedreference | Bell BP, 2008, AM J GASTROENTEROL, V103, P2727, DOI 10.1111/j.1572-0241.2008.02071.x | - |
dc.description.citedreference | Abu-Hilal M, 2008, J GASTROINTEST SURG, V12, P1521, DOI 10.1007/s11605-008-0553-4 | - |
dc.description.citedreference | Naimark DMJ, 2008, MED DECIS MAKING, V28, P706, DOI 10.1177/0272989X08315241 | - |
dc.description.citedreference | Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003 | - |
dc.description.citedreference | Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933 | - |
dc.description.citedreference | Minagawa M, 2007, ANN SURG, V245, P909, DOI 10.1097/01.sla.0000254368.65878.da | - |
dc.description.citedreference | Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079 | - |
dc.description.citedreference | LUPO L, 2007, HPB OXFORD, V9, P429 | - |
dc.description.citedreference | Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176 | - |
dc.description.citedreference | Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8 | - |
dc.description.citedreference | LU MD, 2006, ZHONGHUA YI XUE ZA Z, V86 | - |
dc.description.citedreference | *DEP HLTH HUM SERV, 2006, NAT VIT STAT REP, V54 | - |
dc.description.citedreference | Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933 | - |
dc.description.citedreference | Akahane M, 2005, RADIOGRAPHICS, V25, pS57, DOI 10.1148/rg.25.si055505 | - |
dc.description.citedreference | Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203 | - |
dc.description.citedreference | Livraghi T, 2005, BRIT J SURG, V92, P856, DOI 10.1002/bjs.4986 | - |
dc.description.citedreference | Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892 | - |
dc.description.citedreference | Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247 | - |
dc.description.citedreference | Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003 | - |
dc.description.citedreference | Sala M, 2004, LIVER TRANSPLANT, V10, P1294, DOI 10.1002/lt.20202 | - |
dc.description.citedreference | Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426 | - |
dc.description.citedreference | Shimozawa N, 2004, J AM COLL SURGEONS, V198, P356, DOI 10.1016/j.jamcollsurg.2003.10.017 | - |
dc.description.citedreference | Choi DI, 2004, RADIOLOGY, V230, P135, DOI 10.1148/radiol.2301021182 | - |
dc.description.citedreference | Komorizono Y, 2003, CANCER, V97, P1253, DOI 10.1002/cncr.11168 | - |
dc.description.citedreference | Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047 | - |
dc.description.citedreference | Rhim H, 2003, RADIOGRAPHICS, V23, P123, DOI 10.1148/rg.231025054 | - |
dc.description.citedreference | RHIM H, 2003, RADIOGRAPHICS, V23, P134 | - |
dc.description.citedreference | Mulier S, 2002, BRIT J SURG, V89, P1206 | - |
dc.description.citedreference | Elias D, 2002, BRIT J SURG, V89, P752 | - |
dc.description.citedreference | Wayne JD, 2002, ANN SURG, V235, P722 | - |
dc.description.citedreference | Llovet JM, 2001, HEPATOLOGY, V33, P1124 | - |
dc.description.citedreference | Zhou XD, 2001, CANCER, V91, P1479 | - |
dc.description.citedreference | Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456 | - |
dc.description.citedreference | Wood TF, 2000, ANN SURG ONCOL, V7, P593 | - |
dc.description.citedreference | Maeda T, 2000, HEPATO-GASTROENTEROL, V47, P1063 | - |
dc.description.citedreference | HUNINK MG, 2000, MED DECIS MAKING, V20, P135 | - |
dc.description.citedreference | LIVRAGHI T, 2000, RADIOLOGY, V217, P27 | - |
dc.description.citedreference | Llovet JM, 1999, HEPATOLOGY, V30, P1434 | - |
dc.description.citedreference | Fong YM, 1999, ANN SURG, V229, P790 | - |
dc.description.citedreference | Poon RTP, 1999, ANN SURG, V229, P216 | - |
dc.description.citedreference | Takayama T, 1998, HEPATOLOGY, V28, P1241 | - |
dc.description.citedreference | Ryu M, 1997, JPN J CLIN ONCOL, V27, P251 | - |
dc.description.citedreference | Takenaka K, 1996, ARCH SURG-CHICAGO, V131, P71 | - |
dc.description.citedreference | LIVRAGHI T, 1995, J HEPATOL, V22, P522 | - |
dc.description.citedreference | IKEDA K, 1993, CANCER, V71, P19 | - |
dc.description.citedreference | BECK JR, 1982, AM J MED, V73, P883 | - |
dc.description.tc | 17 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.